Navigation Links
China Cord Blood Corporation Announces Results of 2010 Annual General Meeting
Date:2/22/2011

HONG KONG, Feb. 22, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or "the Company"), the first and largest cord blood banking operator in China, today announced the results of its 2010 Annual General Meeting, which was held on February 18, 2011, in Hong Kong.

At the Annual General Meeting, shareholders

  • elected Albert Chen and Mark Chen to serve on the Board of Directors until the 2013 annual general meeting of the Company or until their respective successors are duly appointed and qualified;

  • ratified the appointment of KPMG as auditor of the Company for the financial year ending March 31, 2011, and authorized the directors to set the remuneration of the auditors; and

  • adopted the 2011 China Cord Blood Corporation Restricted Share Unit Scheme, or the "Incentive Plan," which has a mandate limit of granting rights to receive ordinary shares not exceeding 10.0% of the Company's issued and outstanding share capital, to directors, officers, employees and/or consultants of the Company and its subsidiaries and authorize directors to grant awards and allot and issue shares thereunder.

  • About China Cord Blood CorporationChina Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.  For more informat
    '/>"/>

    SOURCE China Cord Blood Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related biology technology :

    1. China Cord Blood Corporation to Announce Third Quarter Fiscal 2011 Financial Results
    2. China-Biotics to Report Fiscal Year 2011 Third Quarter Financial Results on February 9
    3. China-Biotics, Inc. Provides Preliminary FY2011Third Quarter Revenue
    4. Reportlinker Adds Industrial Biotechnology China News 1011
    5. Reportlinker Adds Financial Health of Biotechnology and Drugs Industry in India and China
    6. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on February 18, 2011
    7. China-Biotics, Inc. to Hold 2010 Annual Meeting of Stockholders on March 9, 2011
    8. China Cord Blood Corporation Announces Completion of Warrant Exchange
    9. China-Biotics Announces Redemption of $25 million in Senior Convertible Notes
    10. China Cord Blood Corporation Announces Participation at the 29th Annual J.P. Morgan Healthcare Conference
    11. PRA International Expert to Speak at China Drug Safety Summit
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/25/2015)... , March 25, 2015  S&P Capital ... Factual Stock Report coverage on Abattis Bioceuticals ... ATTBF; CSE: ATT): is a specialty biotechnology company ... cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, ... in North America . The ...
    (Date:3/25/2015)... -- Accelovance, a therapeutically focused contract research organization (CRO), ... Organization" at the upcoming Vaccine Industry Excellence (ViE) Awards ... This is the eighth consecutive year Accelovance has been ... "Best Contract Research Organization" in 2009, 2010, and 2011, ... "We,re excited to be a finalist for the ...
    (Date:3/25/2015)... An increase of awareness related to benefits of ... nutrients, regulatory changes and concerns related to consumer safety ... natural astaxanthin over the past few years. Producers of ... to satisfy the rising demand. , The global ... in nutraceuticals, aqua feed, food and beverages and cosmetics) ...
    (Date:3/25/2015)... South San Francisco, CA (PRWEB) March 25, 2015 ... Trial Provide Support for Novel Mechanism of Action ... CA, March 25, 2015 – Cytokinetics, Incorporated (Nasdaq: ... to its fast skeletal muscle troponin activator tirasemtiv ... results from a Phase IIa “Evidence of Effect” ...
    Breaking Biology Technology:S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Accelovance Nominated for 2015 Vaccine Industry Excellence (ViE) Awards 2Global Astaxanthin Market to Reach Value of USD 1.1 billion by 2020, Expects Industry Experts in New Report Available at MarketPublishers.com 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
    ... , Multiporator / Electroporator 2510 , , , , , , ... , Protocol No. 4308 915.513 04/2002 , , ... , , Microorganism , ... Cell type , Bacteria, gram negative, , ...
    ... , , , , , Multiporator / Electroporator 2510 , , , ... Transformation Protocol , Protocol No. 4308 915.506 12/2001 ... , , , , , ... , Cell type , ...
    ... , , , , , , Multiporator / Electroporator 2510 , , ... , Transformation Protocol , Protocol No. 4308 ... , , , , , , ... , , Cell type , ...
    Cached Biology Technology:Escherichia coli DH10B 2Escherichia coli DH10B 3Borrelia burgdorferi 2Agrobacterium tumefaciens 2
    (Date:3/23/2015)... March 23, 2015  In the 2014 fiscal year, ... conviction losses. This figure accounts for a fraction of ... The Nilson Report, exceeds $11 billion globally. The polygraph ... a crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test ...
    (Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Hand Geometry - Global Strategic Business Report" report to ... for Hand Geometry in US$ Thousands. The report provides separate ... Japan , Europe , ... , and Rest of World. Annual estimates and ...
    (Date:3/19/2015)... 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host Laura ... to pay, and ,a really big breakthrough in mobile payment.,  ...
    Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
    ... Health Organization (WHO) and the United Nations Children's Fund (UNICEF) ... from measles, a leading vaccine-preventable killer, by the end of ... 873 000 in 1999 to an estimated 530 000 in ... with the highest burden of the disease, where estimated measles ...
    ... Chemistry Professor John T. Fourkas have demonstrated that ... can be induced to emit light so strongly ... single nanoparticle. Fourkas, in collaboration with postdoctoral researcher ... Vincent Chen, coaxed the particles into strong emission ...
    ... us, our mind's eye has a bias. For reasons that ... tendency to devote more visual attention to the left side ... known as pseudoneglect. Researchers now report that pseudoneglect is not ... only that brain structures thought to play a requisite role ...
    Cached Biology News:Measles Deaths Worldwide Drop By Nearly 40% Over Five Years 2Findings have implications for tracking disease, drugs at the molecular level 2The lopsided brain: Attention bias is shared by humans and birds 2
    ...
    Collected from calves that are 10 days old or less. Sterile, cell culture tested, US Origin...
    ... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
    ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
    Biology Products: